The role of infection and inflammation in stillbirths: Parallels with SIDS?

Frontiers in Immunology

Volumn 6, Issue JUN, 2015, Pages

  Blackwell, Caroline ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Cigarette smoke; Ethnicity; Infection; Inflammation; Obesity; Stillbirth; Sudden infant death syndrome

Indexed keywords

ANGIOTENSIN II; APELIN; C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; METALLOPROTEIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHILD DEATH; CHORIOAMNIONITIS; CYTOMEGALOVIRUS INFECTION; DNA POLYMORPHISM; ENTEROVIRUS; ESCHERICHIA COLI INFECTION; FEMALE; FETUS GROWTH; FETUS WASTAGE; GROUP A STREPTOCOCCAL INFECTION; HEREDITY; HUMAN; IMMUNE DYSREGULATION; INFLAMMATION; MALE; OBESITY; OVARY POLYCYSTIC DISEASE; PARVOVIRIDAE; POLYMERASE CHAIN REACTION; PREGNANCY OUTCOME; PREMATURE LABOR; RISK FACTOR; SMOKING; STILLBIRTH; SUDDEN INFANT DEATH SYNDROME; TESTOSTERONE BLOOD LEVEL; UREAPLASMA INFECTION;

EID: 84935099831     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00248     Document Type: Article

References (85)

1. Walsh S, Mortimer G. Unexplained stillbirths and sudden infant death syndrome. Med Hypotheses (1995) 45(1):73-5. doi:10.1016/0306-9877(95)90206-6
2. Tolockiene E, Morsing E, Holst E, Herbst A, Ljungh Å, Svenningsen N, et al. Intrauterine infection may be a major cause of stillbirth in Sweden. Acta Obstet Gynecol Scand (2001) 80(6):511-8. doi:10.1034/j.1600-0412.2001.080006511.x
3. Goldenberg RL, Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol (2003) 189(3):861-73. doi:10.1067/S0002-9378(03)00470-8
4. McClure EM, Goldenberg RL. Infection and stillbirth. Semin Fetal Neonatal Med (2009) 14(4):182-9. doi:10.1016/j.siny.2009.02.003
5. Blackwell CC, Moscovis SM, Gordon AE, Al Madani AM, Hall ST, Gleeson M, et al. Cytokine responses and sudden infant death syndrome: genetic, developmental, and environmental risk factors. J Leukoc Biol (2005) 78:1242-54. doi:10.1189/jlb.0505253
6. Goldwater PN. Sterile site infection at autopsy in sudden unexpected deaths in infancy. Arch Dis Child (2009) 94(4):303-7. doi:10.1136/adc.2007.135939
7. Weber MA, Klein NJ, Hartley JC, Lock PE, Malone M, Sebire NJ. Infection and sudden unexpected death in infancy: a systematic retrospective case review. Lancet (2008) 371(9627):1848-53. doi:10.1016/S0140-6736(08)60798-9
8. Adams MM. The descriptive epidemiology of sudden infant deaths among natives and whites in Alaska. Am J Epidemiol (1985) 122(4):637-43.
9. Alessandri LM, Read AW, Stanley FJ, Burton PR, Dawes VP. Sudden infant death syndrome in aboriginal and non-aboriginal infants. J Paediatr Child Health (1994) 30(3):234-41. doi:10.1111/j.1440-1754.1994.tb00626.x
10. Balarajan R, Soni Raleigh V, Botting B. Sudden infant death syndrome and postneonatal mortality in immigrants in England and Wales. BMJ (1989) 298(6675):716-20. doi:10.1136/bmj.298.6675.716
11. Alessandri LM, Stanley FJ, Waddell VP, Newnham J. Stillbirths in Western Australia 1980-1983: influence of race, residence and place of birth. Aust N Z J Obstet Gynaecol (1988) 28(4):284-92. doi:10.1111/j.1479-828X.1988.tb01684.x
12. Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ (2013) 15:346. doi:10.1136/bmj.f108
13. Rowland Hogue CJ, Silver RM. Racial and ethnic disparities in United States: stillbirth rates: trends, risk factors, and research needs. Semin Perinatol (2010) 35(4):221-33. doi:10.1053/j.semperi.2011.02.019
14. Fleming PJ, Blair PS, Ward Platt M, Tripp J, Smith IJ, Group CSR. Sudden infant death syndrome and social deprivation: assessing epidemiological factors after post-matching for deprivation. Paediatr Perinat Epidemiol (2003) 17(3):272-80. doi:10.1046/j.1365-3016.2003.00465.x
15. Mage DT, Donner M. A unifying theory for SIDS. Int J Pediatr (2009) 368270(10):29. doi:10.1155/2009/368270
16. Strandskov HH, Bisaccia H. The sex ratio of human stillbirths at each month of uterogestation and at conception. Am J Phys Anthropol (1949) 7(2):131-44. doi:10.1002/ajpa.1330070202
17. Ray JG, Urquia ML. Risk of stillbirth at extremes of birth weight between 20 to 41 weeks gestation. J Perinatol (2012) 32(11):829-36. doi:10.1038/jp.2012.60
18. Blair PS, Fleming PJ, Bensley D, Smith I, Bacon C, Taylor E, et al. Smoking and the sudden infant death syndrome: results from 1993-5 case-control study for confidential inquiry into stillbirths and deaths in infancy. Br Med J (1996) 313(7051):195-8. doi:10.1136/bmj.313.7051.195
19. Morris JA. Common bacterial toxins and physiological vulnerability to sudden infant death: the role of deleterious genetic mutations. FEMS Immunol Med Microbiol (2004) 42(1):42-7. doi:10.1016/j.femsim.2004.06.016
20. Blair PS, Ward Platt M, Smith IJ, Fleming PJ. Sudden infant death syndrome and sleeping position in pre-term and low birth weight infants: an opportunity for targeted intervention. Arch Dis Child (2006) 91(2):101-6. doi:10.1136/adc.2004.070391
21. Chen A, Feresu SA, Fernandez C, Rogan WJ. Maternal obesity and the risk of infant death in the United States. Epidemiology (2009) 20(1):74-81. doi:10.1097/EDE.0b013e3181878645
22. Johansson S, Villamor E, Altman M, Bonamy AK, Granath F, Cnattingius S. Maternal overweight and obesity in early pregnancy and risk of infant mortality: a population based cohort study in Sweden. BMJ (2014) 349:g6572. doi:10.1136/bmj.g6572
23. Flenady V, Koopmans L, Middleton P, Frøen JF, Smith GC, Gibbons K, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet (2011) 377(9774):1331-40. doi:10.1016/S0140-6736(10)62233-7
24. Aune D, Saugstad O, Henriksen T, Tonstad S. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis. JAMA (2014) 311(15):1536-46. doi:10.1001/jama.2014.2269
25. Stanton C, Lawn JE, Rahman H, Wilczynska-Ketende K, Hill K. Stillbirth rates: delivering estimates in 190 countries. Lancet (2006) 367(9521):1487-94. doi:10.1016/S0140-6736(06)68586-3
26. Gibbs RS. The origins of stillbirth: infectious diseases. Semin Perinatol (2002) 26(1):75-8. doi:10.1053/sper.2002.29839
27. Quinn PA, Butany J, Chipman M, Taylor J, Hannah W. A prospective study of microbial infection in stillbirths and early neonatal death. Am J Obstet Gynecol (1985) 151(2):238-49. doi:10.1016/0002-9378(85)90020-1
28. Iwasenko JM, Howard J, Arbuckle S, Graf N, Hall B, Craig ME, et al. Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. J Infect Dis (2011) 203(11):1526-33. doi:10.1093/infdis/jir121
29. Gencay M, Koskiniemi M, ÄMmäLä P, Fellman V, NäRväNen ALE, WahlströM T, et al. Chlamydia trachomatis seropositivity is associated both with stillbirth and preterm delivery. APMIS (2000) 108(9):584-8. doi:10.1034/j.1600-0463.2000.d01-101.x
30. Tolfvenstam T, Papadogiannakis N, Norbeck O, Petersson K, Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet (2001) 357(9267):1494-7. doi:10.1016/S0140-6736(00)04647-X
31. Blackwell CC, Gordon AE, James VS, MacKenzie DA, Mogensen-Buchanan M, El Ahmer OR, et al. The role of bacterial toxins in sudden infant death syndrome (SIDS). Int J Med Microbiol (2002) 291(6-7):561-70. doi:10.1078/1438-4221-00168
32. Bettelheim KA, Goldwater PN, Evangelidis H, Pearce JL, Smith DL. Distribution of toxigenic Escherichia coli serotypes in the intestines of infants. Comp Immunol Microbiol Infect Dis (1992) 15(1):65-70. doi:10.1016/0147-9571(92)90103-X
33. Van Bodegom D, May L, Meij HJ, Westendorp RGJ. Regulation of human life histories. Ann N Y Acad Sci (2007) 1100(1):84-97. doi:10.1196/annals.1395.007
34. Ibiebele I, Coory M, Boyle FM, Humphrey M, Vlack S, Flenady V. Stillbirth rates among indigenous and non-indigenous women in Queensland, Australia: is the gap closing? BJOG (2014). doi:10.1111/1471-0528.13047
35. Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant (2002) 2(6):560-7. doi:10.1034/j.1600-6143.2002.20611.x
36. Ness RB, Haggerty CL, Harger G, Ferrell R. Differential distribution of allelic variants in cytokine genes among African Americans and white Americans. Am J Epidemiol (2004) 160(11):1033-8. doi:10.1093/aje/kwh325
37. Moscovis SM, Gordon AE, Al Madani OM, Gleeson M, Scott RJ, Roberts-Thomson J, et al. Interluekin-10 and sudden infant death syndrome. FEMS Immunol Med Microbiol (2004) 42:130-8. doi:10.1016/j.femsim.2004.06.005
38. Moscovis SM, Gordon AE, Al Madani OM, Gleeson M, Scott RJ, Roberts-Thomson J, et al. Interleukin-1b and sudden infant death syndrome. FEMS Immunol Med Microbiol (2004) 42:139-45. doi:10.1016/j.femsim.2004.06.005
39. Moscovis SM, Gordon AE, Al Madani OM, Gleeson M, Scott RJ, Roberts-Thomson J, et al. IL6 G-174C associated with sudden infant death syndrome in Caucasian Australian infants. Hum Immunol (2006) 67:819-25. doi:10.1016/j.humimm.2006.07.010
40. Cox AJ, Moscovis SM, Blackwell CC, Scott RJ. Cytokine gene polymorphism among indigenous Australians. Innate Immun (2014) 20(4):431-9. doi:10.1177/1753425913498911
41. Simhan HN, Krohn MA, Roberts JM, Zeevi A, Caritis SN. Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol (2003) 189(4):915-8. doi:10.1067/S0002-9378(03)00843-3
42. Goepfert AR, Jeffcoat MK, Andrews WW, Faye-Petersen O, Cliver SP, Goldenberg RL, et al. Periodontal disease and upper genital tract inflammation in early spontaneous preterm birth. Obstet Gynecol (2004) 104(4):777-83. doi:10.1097/01.AOG.0000139836.47777.6d
43. Velez D, Fortunato S, Morgan N, Edwards T, Lombardi S, Williams S, et al. Patterns of cytokine profiles differ with pregnancy outcome and ethnicity. Hum Reprod (2008) 23(8):1902-9. doi:10.1093/humrep/den170
44. Wenstrom KD, Andrews WW, Hauth JC, Goldenberg RL, DuBard MB, Cliver SP. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol (1998) 178(3):546-50. doi:10.1016/S0002-9378(98)70436-3
45. Frøen JF, Arnestad M, Vege Å, Irgens LM, Rognum TO, Saugstad OD, et al. Comparative epidemiology of sudden infant death syndrome and sudden intrauterine unexplained death. Arch Dis Child (2002) 87(2):F118-21. doi:10.1136/fn.87.2.F118
46. Pinar H, Goldenberg RL, Koch MA, Heim-Hall J, Hawkins HK, Shehata B, et al. Placental findings in singleton stillbirths. Obstet Gynecol (2014) 123(2, Pt 1):325-36. doi:10.1097/AOG.0000000000000100
47. Hulthén Varli I, Kublickas M, Papadogiannakis N, Petersson K. Chorioamnionitis without foetal inflammatory response is associated with stillbirth in early preterm pregnancies. J Matern Fetal Neonatal Med (2013) 26(10):953-9. doi:10.3109/14767058.2013.766706
48. Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med (2007) 25(01):021-39. doi:10.1055/s-2006-956773
49. Burns C, Hall ST, Smith R, Blackwell C. Cytokine levels in late pregnancy: are female infants better protected against inflammation?. Front Immunol (2015) 6:318. doi:10.3389/fimmu.2015.00318
50. Moscovis S, Hall S, Burns C, Scott R, Blackwell C. Development of an experimental model for assessing the effects of cigarette smoke and virus infections on inflammatory responses to bacterial antigens. Innate Immun (2014) 20(6):647-58. doi:10.1177/1753425913503893
51. Larcombe L, Rempel JD, Dembinski I, Tinckam K, Rigatto C, Nickerson P. Differential cytokine genotype frequencies among Canadian aboriginal and Caucasian populations. Genes Immun (2004) 6(2):140-4. doi:10.1038/sj.gene.6364157
52. Park J, CW P, Lockwood C, ER N. Role of cytokines in preterm birth ad birth. Minerva Ginecol (2005) 57(4):349-66.
53. Holst D, Garnier Y. Preterm birth and inflammation -the role of genetic polymorphisms. Eur J Obstet Gynecol Reprod Biol (2008) 141(1):3-9. doi:10.1016/j.ejogrb.2008.07.020
54. Shobokshi A, Shaarawy M. Maternal serum and amniotic fluid cytokines in patients with preterm premature rupture of membranes with and without intrauterine infection. Int J Gynaecol Obstet (2002) 79(3):209-15. doi:10.1016/S0020-7292(02)00238-2
55. Daher S, Denardi KDAG, Blotta MHSSL, Mamoni RL, Reck APM, Camano L, et al. Cytokines in recurrent pregnancy loss. J Reprod Immunol (2004) 62(1):151-7. doi:10.1016/j.jri.2003.10.004
56. Romero R, Espinoza J, Chaiworapongsa T, Kalache K. Infection and prematurity and the role of preventive strategies. Semin Neonatol (2002) 7(4):259-74. doi:10.1053/siny.2002.0121
57. Haun L, Kwan N, Hollier L. Viral infections in pregnancy. Minerva Ginecol (2007) 59(2):159-74.
58. Lundemose JB, Smith H, Sweet C. Cytokine release from human peripheral blood leucocytes incubated with endotoxin with and without prior infection with influenza virus: relevance to the sudden infant death syndrome. Int J Exp Pathol (1993) 74(3):291-7.
59. Sarawar SR, Blackman MA, Doherty PC. Superantigen shock in mice with an inapparent viral infection. J Infect Dis (1994) 170(5):1189-94. doi:10.1093/infdis/170.5.1189
60. Blood-Siegfried J, Shelton B. Animal models of sudden unexplained death. FEMS Immunol Med Microbiol (2004) 42(1):34-41. doi:10.1016/j.femsim.2004.06.009
61. Cardenas I, Mor G, Aldo P, Lang SM, Stabach P, Sharp A, et al. Placental viral infection sensitizes to endotoxin-induced pre-term labor: a double hit hypothesis. Am J Reprod Immunol (2011) 65(2):110-7. doi:10.1111/j.1600-0897.2010.00908.x
62. Moscovis SM, Hall ST, Burns CJ, Scott RJ, Blackwell CC. The male excess in sudden infant deaths. Innate Immun (2014) 20(1):24-9. doi:10.1177/1753425913481071
63. McDonald SP, Maguire GP, Duarte N, Wang XL, Hoy WE. Carotid intima-media thickness, cardiovascular risk factors and albuminuria in a remote Australian aboriginal community. Atherosclerosis (2004) 177(2):423-31. doi:10.1016/j.atherosclerosis.2004.08.004
64. Eslick GD, Yan P, Xia HHX, Murray H, Spurrett B, Talley NJ. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther (2002) 16(9):1677-82. doi:10.1046/j.1365-2036.2002.01333.x
65. Sharma A, Ramesh A, Thomas B. Evaluation of plasma C-reactive protein levels in pregnant women with and without periodontal disease: a comparative study. J Indian Soc Periodontol (2009) 13(3):145-9. doi:10.4103/0972-124X.60227
66. El Ahmer OR, Essery SD, Saadi AT, Raza MW, Ogilvie MM, Weir DM, et al. The effect of cigarette smoke on adherence of respiratory pathogens to buccal epithelial cells. FEMS Immunol Med Microbiol (1999) 23(1):27-36. doi:10.1016/S0928-8244(98)00114-X
67. Murphy SP, Fast LD, Hanna NN, Sharma S. Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J Immunol (2005) 175(6):4084-90. doi:10.4049/jimmunol.175.6.4084
68. Robertson SA, Skinner RJ, Care AS. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol (2006) 177(7):4888-96. doi:10.4049/jimmunol.177.7.4888
69. Robertson SA, Care AS, Skinner RJ. Interleukin 10 regulates I inflammatory cytokine synthesis to protect against lipopolysaccharide-induced abortion and fetal growth restriction in mice. Biol Reprod (2007) 76(5):738-48. doi:10.1095/biolreprod.106.056143
70. Kang X, Kim H-J, Ramirez M, Salameh S, Ma X. The septic shock-associated IL-10 -1082 A > G polymorphism mediates allele-specific transcription via poly(ADP-ribose) polymerase 1 in macrophages engulfing apoptotic cells. J Immunol (2010) 184(7):3718-24. doi:10.4049/jimmunol.0903613
71. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet (1997) 24(1):1-8. doi:10.1111/j.1365-2370.1997.tb00001.x
72. Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm (2013) 22(139239):22. doi:10.1155/2013/139239
73. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metabol (1998) 83(3):847-50. doi:10.1210/jcem.83.3.4660
74. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metabol (1997) 82(5):1313-6. doi:10.1210/jcem.82.5.3950
75. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care (1999) 22(12):1971-7. doi:10.2337/diacare.22.12.1971
76. Karin P, Katarina B, Roger B, Alexandra H, Ingela H-V, Marius K, et al. Diagnostic evaluation of intrauterine fetal deaths in Stockholm 1998-99. Acta Obstet Gynecol Scand (2002) 81(4):284-92. doi:10.1034/j.1600-0412.2002.810402.x
77. Amu S, Hahn-Zoric M, Malik A, Ashraf R, Zaman S, Kjellmer I, et al. Cytokines in the placenta of Pakistani newborns with and without intrauterine growth retardation. Pediatr Res (2006) 59(2):254-8. doi:10.1203/01.pdr.0000196332.37565.7d
78. Ernst GDS, de Jonge LL, Hofman A, Lindemans J, Russcher H, Steegers EAP, et al. C-reactive protein levels in early pregnancy, fetal growth patterns, and the risk for neonatal complications: the generation R study. Am J Obstet Gynecol (2011) 205(2):.e1-12. doi:10.1016/j.ajog.2011.03.049
79. Rivera DL, Olister SM, Liu X, Thompson JH, Zhang X, Pennline K, et al. Interleukin-10 attenuates experimental fetal growth restriction and demise. FASEB J (1998) 12(2):189-97.
80. Yamamoto-Tabata T, McDonagh S, Chang H-T, Fisher S, Pereira L. Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J Virol (2004) 78(6):2831-40. doi:10.1128/JVI.78.6.2831-2840.2004
81. Steckler T, Wang J, Bartol FF, Roy S, Padmanabhan V. Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment. Endocrinology (2005) 146(7):3185-93. doi:10.1210/en.2004-1444
82. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Pérez-Bravo F, Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod (2002) 17(10):2573-9. doi:10.1093/humrep/17.10.2573
83. Sir-Petermann T, Hitchsfeld C, Maliqueo M, Codner E, Echiburú B, Gazitúa R, et al. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod (2005) 20(8):2122-6. doi:10.1093/humrep/dei009
84. Carlsen SM, Jacobsen G, Romundstad P. Maternal testosterone levels during pregnancy are associated with offspring size at birth. Eur J Endocrinol (2006) 155(2):365-70. doi:10.1530/eje.1.02200
85. Gitau R, Adams D, Fisk NM, Glover V. Fetal plasma testosterone correlates positively with cortisol. Arch Dis Child Fetal Neonatal Ed (2005) 90(2):F166-9. doi:10.1136/adc.2004.049320